Cargando…

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Pancreatic neuroendocrine tumors (PNETs) are rare primary neoplasms of the pancreas and arise sporadically or in the context of genetically determined syndromes. Depending on hormone production and sensing, PNETs clinically manifest due to a hormone-related syndrome (functional PNET) or by symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehehalt, Florian, Franke, Ellen, Pilarsky, Christian, Grützmann, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840460/ https://www.ncbi.nlm.nih.gov/pubmed/24281208 http://dx.doi.org/10.3390/cancers2041901

Ejemplares similares

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

The Role of Exosomes in Pancreatic Cancer
por: Lan, Bin, et al.
Publicado: (2019)

Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
por: Brunner, Maximilian, et al.
Publicado: (2019)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

The Role of Apoptosis in the Pathology of Pancreatic Cancer
por: Samm, Nicole, et al.
Publicado: (2010)

Neoadjuvant Therapy in Patients with Pancreatic Cancer: A Disappointing Therapeutic Approach?
por: Zimmermann, Carolin, et al.
Publicado: (2011)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment
por: Alshareefy, Yasir, et al.
Publicado: (2023)

Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
por: Maharjan, Chandra K., et al.
Publicado: (2021)

Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
por: Wiesmueller, Felix, et al.
Publicado: (2019)

Feedback within the Inter-Cellular Communication and Tumorigenesis in Carcinomas
por: Rückert, Felix, et al.
Publicado: (2012)

Pancreatic Neuroendocrine Tumors Complicated by Sinistral Portal Hypertension: Insights into Pathogenesis
por: Moyana, Terence N., et al.
Publicado: (2017)

Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013)

Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Identification of Prognostic Biomarkers by Combined mRNA and miRNA Expression Microarray Analysis in Pancreatic Cancer
por: Liu, Bin, et al.
Publicado: (2018)

Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020)

CRISPR/Cas9-Mediated Knock-Out of Kras(G12D) Mutated Pancreatic Cancer Cell Lines
por: Lentsch, Eva, et al.
Publicado: (2019)

Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development
por: Langheinrich, Melanie, et al.
Publicado: (2020)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer
por: Treppiedi, Donatella, et al.
Publicado: (2022)

Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors
por: Chatani, Praveen Dilip, et al.
Publicado: (2021)

Diagnosis of Pancreatic Neuroendocrine Tumors
por: Lee, Dong Wook, et al.
Publicado: (2017)

Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
por: Ro, Cynthia, et al.
Publicado: (2013)

An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
por: Yun, Duo, et al.
Publicado: (2022)

Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
por: Cen, Putao, et al.
Publicado: (2012)

Neuroendocrine Factors in Melanoma Pathogenesis
por: Scheau, Cristian, et al.
Publicado: (2021)

Impact of CRISPR/Cas9-Mediated CD73 Knockout in Pancreatic Cancer
por: Zhang, Jinping, et al.
Publicado: (2023)

Recent developments in imaging of pancreatic neuroendocrine tumors
por: Kartalis, Nikolaos, et al.
Publicado: (2015)

Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translation
por: Shen, Xiaofei, et al.
Publicado: (2022)

Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and Metastases
por: Guo, Yiying, et al.
Publicado: (2023)

Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
por: Kulke, Matthew H, et al.
Publicado: (2011)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
por: Yim, Kein-Leong
Publicado: (2012)

Pancreatic neuroendocrine tumors: the basics, the gray zone, and the target
por: Kelgiorgi, Dionysia, et al.
Publicado: (2017)

Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
por: Mpilla, Gabriel Benyomo, et al.
Publicado: (2020)

Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms
por: Pozas, Javier, et al.
Publicado: (2019)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imcqbo2g7kqvbfema4q9gvkcvf